.comment-link {margin-left:.6em;}

Tuesday, July 25, 2006

 

SHIRE ANNOUNCES FILING OF SPD465 FOR THE TREATMENT OF ADULT ADHD

Shire is seeking FDA approval for SPD465, which contains the same active ingredient as Adderall XR. SPD465 will control AD/HD symptoms for up to 16 hours. Click on the link above for more details.

Comments: Post a Comment

Links to this post:

Create a Link



<< Home

This page is powered by Blogger. Isn't yours?